{"nct_id":"NCT00504790","title":"Phase I Study to Assess the Safety, Pharmacokinetics, & Pharmacodynamics of GSK923295 in Subjects w/ Refractory Cancer","status":"COMPLETED","status_verified_date":"2018-07","start_date":"2007-06-25","start_date_type":"ACTUAL","primary_completion_date":"2012-05-07","primary_completion_date_type":"ACTUAL","completion_date":"2012-05-08","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["GSK"]}